The clinical spectrum of invasive pulmonary aspergillosis (IPA) has expanded in recent decades. A large group of patients admitted to intensive care units (ICU) is indeed susceptible to the development of IPA. Although timely diagnosis and antifungal therapy of IPA in this expanding population is crucial to prevent IPA-related deaths, the magnitude of the favorable prognostic impact of antifungal therapy is difficult to measure precisely. In our opinion, the development of standardized research definitions could have favorable implications for further improving our ability both to measure the favorable effect of antifungal treatment and to prevent IPA-related death in ICU patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11283379PMC
http://dx.doi.org/10.1007/s11046-024-00879-6DOI Listing

Publication Analysis

Top Keywords

antifungal treatment
8
invasive pulmonary
8
pulmonary aspergillosis
8
intensive care
8
antifungal therapy
8
prevent ipa-related
8
optimizing antifungal
4
treatment strategies
4
strategies prevent
4
prevent invasive
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!